0000000000404393

AUTHOR

Ciberesp Cases

showing 3 related works from this author

No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity

2015

Garcia-Etxebarria, Koldo et al.

MaleGenotypeRisk factors in diseaseslcsh:MedicineGenome-wide association studySingle-nucleotide polymorphismDiseaseBiologyBioinformaticsmedicine.disease_causePolymorphism Single NucleotideSeverity of Illness IndexGripInfluenza A Virus H1N1 SubtypeGene FrequencyRisk FactorsGenotypeSeverity of illnessInfluenza HumanInfluenza A virusmedicineSNPHumanslcsh:ScienceAllele frequencyMultidisciplinaryFactors de risc en les malaltieslcsh:RGenomicsInfluenzaGenòmicaEstudi de casosRNA ViralRNAFemalelcsh:QCase studiesResearch Article
researchProduct

Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza dur…

2013

Background: Since influenza predisposes to bacterial pneumonia caused by Streptococcus pneumoniae, studies have suggested that pneumococcal vaccination might reduce its occurrence during pandemics. We assessed the effectiveness of pneumococcal polysaccharide vaccination alone and in combination with influenza vaccination in preventing influenza hospitalization during the 2009–2010 pandemic wave and 2010–2011 influenza epidemic. Methods: We conducted a multicenter case-control study in 36 Spanish hospitals. We selected patients aged ≥ 18 y hospitalized with confirmed influenza and two hospitalized controls per case, matched according to age, date of hospitalization and province of residence.…

AdultMalemedicine.medical_specialtyAdolescentInfluenza vaccineImmunologymedicine.disease_causePneumococcal VaccinesYoung AdultInternal medicineStreptococcus pneumoniaePandemicInfluenza HumanmedicineImmunology and AllergyHumansYoung adultAgedPharmacologyAged 80 and overbusiness.industryBacterial pneumoniaCase-control studyvirus diseasesMiddle AgedPneumonia Pneumococcalmedicine.diseasePneumococcal polysaccharide vaccineVaccinationHospitalizationInfluenza VaccinesSpainCase-Control StudiesImmunologyCosts and Cost AnalysisFemalebusinessResearch Paper
researchProduct

Smoking may increase the risk of influenza hospitalization and reduce influenza vaccine effectiveness in the elderly.

2017

Background Through its effects on the immune system, smoking may facilitate influenza virus infection, its severity and its most frequent complications. The objective was to investigate the smoking history as a risk factor for influenza hospitalization and influenza vaccine effectiveness in elderly smokers/ex-smokers and non-smokers. Methods We carried out a multicenter case-control study in the 2013-2014 and 2014-2015 influenza seasons. Cases aged ≥65 years and age-, sex-matched controls were selected from 20 Spanish hospitals. We collected epidemiological variables, comorbidities, vaccination history and the smoking history. The risk of hospitalization due to smoking (current smokers and …

Malemedicine.medical_specialtyInfluenza vaccineComorbidity03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineEpidemiologyInfluenza HumanMedicineHumans030212 general & internal medicineRisk factorGeriatric AssessmentAgedAged 80 and overbusiness.industrySmokingPublic Health Environmental and Occupational HealthCase-control studyOdds ratiomedicine.diseaseComorbidityVaccinationHospitalizationIncreased riskTreatment Outcome030228 respiratory systemInfluenza VaccinesSpainCase-Control StudiesFemaleMedical emergencybusinessEuropean journal of public health
researchProduct